| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-03602-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61805-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-97867-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75910SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11980-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52681-0.025mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| CoraFluor 1 | NBP2-34729CL1 | |||
| FITC | NBP2-34729F | |||
| Janelia Fluor 525 | NBP2-34729JF525 | |||
| Janelia Fluor 669 | NBP2-34729JF669 | |||
| mFluor Violet 450 SE | NBP2-34729MFV450 | |||
| mFluor Violet 500 SE | NBP2-34729MFV500 | |||
| mFluor Violet 610 SE | NBP2-34729MFV610 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-48471 | |||
| Azide and BSA Free | NBP2-34729-0.1mg | |||
![Western Blot: HLA DQA1 Antibody [NBP3-03602] - Analysis of extracts of various cell lines, using HLA DQA1 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-Western-Blot-NBP3-03602-img0003.jpg "Western Blot: HLA DQA1 Antibody [NBP3-03602] - Analysis of extracts of various cell lines, using HLA DQA1 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.")
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody [NBP3-03602] - Paraffin-embedded human esophagus using HLA DQA1 antibody at dilution of 1:100 (40x lens).](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-Immunohistochemistry-Paraffin-NBP3-03602-img0002.jpg)
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody [NBP3-03602] - Paraffin-embedded human prostate using HLA DQA1 antibody at dilution of 1:100 (40x lens).](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-Immunohistochemistry-Paraffin-NBP3-03602-img0001.jpg)
![Western Blot: ORAI3 Antibody [NBP2-82014] - Western blot analysis of ORAI3 in A20 cell lysate with ORAI3 antibody at (A) 2 and (B) 4 ug/mL.](http://images.novusbio.com/fullsize/ORAI3-Antibody-Western-Blot-NBP2-82014-img0001.jpg "Western Blot: ORAI3 Antibody [NBP2-82014] - Western blot analysis of ORAI3 in A20 cell lysate with ORAI3 antibody at (A) 2 and (B) 4 ug/mL.")
![Immunocytochemistry/Immunofluorescence: ORAI3 Antibody [NBP2-82014] - Immunofluorescence of ORAI3 in A20 cells with ORAI3 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/ORAI3-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-82014-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: ORAI3 Antibody - BSA Free [NBP2-82014] - Immunocytochemistry of ORAI3 in A20 cells with ORAI3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-82014_rabbit-polyclonal-orai3-antibody-2711202419261885.jpg)
![Western Blot: KIR3DL1 Antibody (6D9A4) [NBP2-61805] - Analysis using KIR3DL1 mAb against human KIR3DL1 (AA: extra 22-340) recombinant protein. (Expected MW is 65 kDa)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9A4-Western-Blot-NBP2-61805-img0003.jpg "Western Blot: KIR3DL1 Antibody (6D9A4) [NBP2-61805] - Analysis using KIR3DL1 mAb against human KIR3DL1 (AA: extra 22-340) recombinant protein. (Expected MW is 65 kDa)")
![Western Blot: KIR3DL1 Antibody (6D9A4) [NBP2-61805] - Analysis using KIR3DL1 mouse mAb against A431 (1), Raji (2), SPC-A-1 (3), K562 (4), HEK293 (5), U937 (6), and C6 (7) cell lysate.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9A4-Western-Blot-NBP2-61805-img0004.jpg)
![ELISA: KIR3DL1 Antibody (6D9A4) [NBP2-61805] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9A4-ELISA-NBP2-61805-img0001.jpg)
![ELISA: KIR3DL1 Antibody (6D9A4) [NBP2-61805] - Analysis of Jurkat cells using KIR3DL1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9A4-ELISA-NBP2-61805-img0002.jpg)
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (AP-MAB0710) [NB110-97867] - Formalin fixed and paraffin embedded mouse spleen tissue section was subjected to immunohistochemistry staining of CD25.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-AP-MAB0710-Immunohistochemistry-Paraffin-NB110-97867-img0003.jpg "Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (AP-MAB0710) [NB110-97867] - Formalin fixed and paraffin embedded mouse spleen tissue section was subjected to immunohistochemistry staining of CD25.")
![Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Immunohistochemistry-NBP2-75910-img0002.jpg "Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.")
![Western Blot: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Human thyroid tumour samples were resolved on a 15% SDS PAGE gel and blots probed with the human IgG4-chimeric version of CE9.1 (NBP2-75910) at 1.5 ug/ml before detection using an anti-human IgG4 secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD4 is 51kDa (arrowhead). Here some non-specific bands can also be seen. NBP2-75910 successfully detected CD4 in human thyroid tissue samples.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Western-Blot-NBP2-75910-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: B220/CD45R Antibody (RA3-6B2) - Chimeric [NBP3-11980] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of RA3-6B2 (NBP3-11980) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11980, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody (NBP2-52638) followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-RA3-6B2-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-11980-img0001.jpg "Immunocytochemistry/Immunofluorescence: B220/CD45R Antibody (RA3-6B2) - Chimeric [NBP3-11980] - Immunofluorescence analysis of paraformaldehyde fixed mouse splenocytes immobilized on Shi-fix(TM) cover-slips and stained with the chimeric rabbit IgG version of RA3-6B2 (NBP3-11980) at 10 ug/ml followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11980, DAPI, merged channels and an isotype control. The isotype control was stained with anti-Fluorescein antibody (NBP2-52638) followed by Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: B220/CD45R Antibody (RA3-6B2) - Chimeric [NBP3-11980] - Mouse splenocytes were stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG1 version of RA3-6B2 (NBP3-11980, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-RA3-6B2-Chimeric-Flow-Cytometry-NBP3-11980-img0002.jpg)
![Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Flow-Cytometry-NBP2-52681-img0001.jpg "Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Immunohistochemistry-Paraffin: TNF-alpha Antibody (TNF706 + P/T2) [NBP2-34304] - Formalin-fixed, paraffin-embedded human Erdheim Chester disease (also known as polyostotic sclerosing histiocytosis) stained with TNF alpha Monoclonal Antibody (TNF706 + P/T2).](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-TNF706-+-P-T2-Immunohistochemistry-Paraffin-NBP2-34304-img0001.jpg "Immunohistochemistry-Paraffin: TNF-alpha Antibody (TNF706 + P/T2) [NBP2-34304] - Formalin-fixed, paraffin-embedded human Erdheim Chester disease (also known as polyostotic sclerosing histiocytosis) stained with TNF alpha Monoclonal Antibody (TNF706 + P/T2).")
![Western Blot: KIR3DL1 Antibody [NBP1-31609] - Sample(30 ug whole cell lysate)A:A431 B:H129910% SDS PAGE, antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-Western-Blot-NBP1-31609-img0002.jpg "Western Blot: KIR3DL1 Antibody [NBP1-31609] - Sample(30 ug whole cell lysate)A:A431 B:H129910% SDS PAGE, antibody diluted at 1:1000.")
![Immunohistochemistry-Paraffin: TLR5 Antibody (8-1#) [NBP3-41489] - DAB staining on IHC-P; Sample: Rat Lymph node Tissue; Primary Ab: 20ug/ml NBP3-41489; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41489_mouse-tlr5-mab-8-1-612202420503623.jpg "Immunohistochemistry-Paraffin: TLR5 Antibody (8-1#) [NBP3-41489] - DAB staining on IHC-P; Sample: Rat Lymph node Tissue; Primary Ab: 20ug/ml NBP3-41489; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Western Blot: TLR5 Antibody (8-1#) [NBP3-41489] - Sample: Recombinant TLR5, Human.](http://images.novusbio.com/fullsize/nbp3-41489_mouse-tlr5-mab-8-1-612202421243247.jpg)
![Western Blot: TLR5 Antibody (8-1#) [NBP3-41489] - Sample: Rat Spleen lysate Primary Ab: 0.6ug/ml NBP3-41489; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41489_mouse-tlr5-mab-8-1-61220242142312.jpg)